Current and future antimicrobial treatment of gonorrhoea – the rapidly evolving Neisseria gonorrhoeae continues to challenge

Neisseria gonorrhoeae has developed antimicrobial resistance (AMR) to all drugs previously and currently recommended for empirical monotherapy of gonorrhoea. In vitro resistance, including high-level, to the last option ceftriaxone and sporadic failures to treat pharyngeal gonorrhoea with ceftriaxon...

Descripción completa

Detalles Bibliográficos
Autor principal: Unemo, Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546108/
https://www.ncbi.nlm.nih.gov/pubmed/26293005
http://dx.doi.org/10.1186/s12879-015-1029-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546108/
https://www.ncbi.nlm.nih.gov/pubmed/26293005
http://dx.doi.org/10.1186/s12879-015-1029-2

Ejemplares similares